Baseline COVID-19 Research Project Explores Vaccine Sentiments and Usage
Vaccines are a powerful tool for recovering from the COVID-19 pandemic. In order for the vaccines to be effective, public trust and effective distribution are critical. Experts estimate that about 70% of the U.S. population will need to receive the vaccine in order to achieve herd immunity and start to return to normal life.
The U.S. vaccination program faces a number of challenges, and much more work remains to be done on tackling both the efficiency of distribution and vaccine hesitancy. By studying both aspects of the vaccine campaigns, Project Baseline’s research goal is to gain insights that can help support a smooth rollout.
The Baseline COVID-19 Research Project is launching new online research activities focused on:
- Vaccine sentiments: participants' thoughts, feelings, and perceptions of vaccination
- Vaccine usage: date, dosage, and other key information about vaccination, for those able to receive a vaccine
Given widespread disinformation, understanding the perceptions of COVID-19 vaccines is a particularly urgent priority. Within our own research community, understanding members' feelings and open questions can provide guidance where we can help by providing relevant scientific information. We're surveying the more than 150,000 members of the community to learn sentiments across different demographic groups, including any concerns and how informed they feel to make the decision to receive the vaccine.
We're also tracking vaccine uptake and usage within the community. There are currently three vaccines from Pfizer, Moderna and Johnson and Johnson, respectively, approved to use in the U.S., and that number may increase. After vaccines are available, a standard part of the clinical research process involves continuing to monitor how people do over the long term. Our research is intended to help generate data about the rollout itself by tracking which vaccines people receive, demographics of vaccine recipients, any side effects like arm pain, and adherence to returning for the second dose.
We look forward to sharing the results with the community. To learn more about or sign up for the COVID-19 Research Project, visit our website.